168 related articles for article (PubMed ID: 2159370)
1. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer.
Hensel CH; Hsieh CL; Gazdar AF; Johnson BE; Sakaguchi AY; Naylor SL; Lee WH; Lee EY
Cancer Res; 1990 May; 50(10):3067-72. PubMed ID: 2159370
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in structure and expression of the retinoblastoma gene in small cell lung cancer cell lines and xenografts in nude mice.
Rygaard K; Sorenson GD; Pettengill OS; Cate CC; Spang-Thomsen M
Cancer Res; 1990 Sep; 50(17):5312-7. PubMed ID: 2167152
[TBL] [Abstract][Full Text] [Related]
3. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
4. Variable mutations of the RB gene in small-cell lung carcinoma.
Mori N; Yokota J; Akiyama T; Sameshima Y; Okamoto A; Mizoguchi H; Toyoshima K; Sugimura T; Terada M
Oncogene; 1990 Nov; 5(11):1713-7. PubMed ID: 2176283
[TBL] [Abstract][Full Text] [Related]
5. Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p.
Miller YE; Minna JD; Gazdar AF
J Clin Invest; 1989 Jun; 83(6):2120-4. PubMed ID: 2542383
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.
Yokota J; Akiyama T; Fung YK; Benedict WF; Namba Y; Hanaoka M; Wada M; Terasaki T; Shimosato Y; Sugimura T
Oncogene; 1988 Oct; 3(4):471-5. PubMed ID: 2856251
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
8. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
9. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen.
Shew JY; Chen PL; Bookstein R; Lee EY; Lee WH
Cell Growth Differ; 1990 Jan; 1(1):17-25. PubMed ID: 1964074
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ
Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618
[TBL] [Abstract][Full Text] [Related]
11. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.
Otterson GA; Kratzke RA; Coxon A; Kim YW; Kaye FJ
Oncogene; 1994 Nov; 9(11):3375-8. PubMed ID: 7936665
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations.
Ookawa K; Shiseki M; Takahashi R; Yoshida Y; Terada M; Yokota J
Oncogene; 1993 Aug; 8(8):2175-81. PubMed ID: 8393162
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma and retinoblastoma gene expression.
Lin CT; Chan WY; Chen W; Shew JY
Lab Invest; 1992 Jul; 67(1):56-70. PubMed ID: 1625448
[TBL] [Abstract][Full Text] [Related]
14. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
16. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
Daly MC; Xiang RH; Buchhagen D; Hensel CH; Garcia DK; Killary AM; Minna JD; Naylor SL
Oncogene; 1993 Jul; 8(7):1721-9. PubMed ID: 8390035
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting.
Kohno T; Morishita K; Takano H; Shapiro DN; Yokota J
Oncogene; 1994 Jan; 9(1):103-8. PubMed ID: 7905618
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
[TBL] [Abstract][Full Text] [Related]
19. Multiple genetic alterations in small-cell lung carcinoma.
Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
[TBL] [Abstract][Full Text] [Related]
20. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.
Hosoe S; Ueno K; Shigedo Y; Tachibana I; Osaki T; Kumagai T; Tanio Y; Kawase I; Nakamura Y; Kishimoto T
Cancer Res; 1994 Apr; 54(7):1787-90. PubMed ID: 7907944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
